z-logo
open-access-imgOpen Access
Combined Arterial Spin Labeling and Diffusion-Weighted Imaging for Noninvasive Estimation of Capillary Volume Fraction and Permeability-Surface Product in the Human Brain
Author(s) -
Patrick W. Hales,
Chris A. Clark
Publication year - 2012
Publication title -
journal of cerebral blood flow and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.167
H-Index - 193
eISSN - 1559-7016
pISSN - 0271-678X
DOI - 10.1038/jcbfm.2012.125
Subject(s) - reproducibility , cerebral blood flow , diffusion mri , nuclear medicine , repeatability , biomedical engineering , voxel , nuclear magnetic resonance , medicine , magnetic resonance imaging , chemistry , chromatography , anesthesia , physics , radiology
A number of two-compartment models have been developed for the analysis of arterial spin labeling (ASL) data, from which both cerebral blood flow ( CBF) and capillary permeability-surface product ( PS) can be estimated. To derive values of PS, the volume fraction of the ASL signal arising from the intravascular space ( v bw ) must be known a priori. We examined the use of diffusion-weighted imaging (DWI) and subsequent analysis using the intravoxel incoherent motion model to determine v bw in the human brain. These data were then used in a two-compartment ASL model to estimate PS. Imaging was performed in 10 healthy adult subjects, and repeated in five subjects to test reproducibility. In gray matter (excluding large arteries), mean voxel-wise v bw was 2.3 ± 0.2 mL blood/100 g tissue (all subjects mean ± s.d.), and CBF and PS were 44 ± 5 and 108 ± 2 mL per 100 g per minute, respectively. After spatial smoothing using a 6-mm full width at half maximum Gaussian kernel, the coefficient of repeatability of CBF, v bw and PS were 8 mL per 100 g per minute, 0.4 mL blood/100 g tissue, and 13 mL per 100 g per minute, respectively. Our results show that the combined use of ASL and DWI can provide a new, noninvasive methodology for estimating v bw and PS directly, with reproducibility that is sufficient for clinical use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom